Compare HTX (HTX) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HTX vs Injective — how do they compare? HTX trades at Rp0.0325 (market cap Rp29,22T, Rp808,5M 24h volume), while Injective trades at Rp92,698 (market cap Rp9,26T, Rp1,75T 24h volume). The key difference: HTX is far larger — about 3.2× Injective's market cap, and HTX's supply is capped (898,2T / 1.000T HTX (90%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold HTX for 20 Days and Injective for 36 Days on average.
| HTX | INJ | |
|---|---|---|
Market Cap | Rp29,22T | Rp9,26T |
Volume (24h) | Rp808,5M | Rp1,75T |
Circulating Supply | 898,2T / 1.000T HTX (90%) | 100M INJ |
Typical Hold Time | 20 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HTX token trades at Rp0.03284 with a market cap of Rp29.37T, showing a bullish technical signal driven by strong moving averages. The circulating supply is 898.2T out of 1.000T max, with a 90% circulation rate and average hold time of 20 days. RSI_12 indicates overbought conditions at 83.21, while ADX signals strong trend momentum. No recent protocol updates or ecosystem news are available.
Overall outlook is cautiously optimistic due to bullish technicals, but high RSI suggests potential short-term pullback. Key opportunities include network growth if adoption increases, while risks involve volatility from overbought signals and lack of recent developments. Investors should monitor trading volume and on-chain activity for confirmation.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HTX
HTX is the native token of HTX DAO, a decentralized organization that supports the decentralized economy. It facilitates transactions, offers fee discounts, and provides access to exclusive features and services. Token holders can also participate in governance through voting. HTX is designed to support contributors, community programs, partnerships, and platform growth while promoting liquidity through voluntary pledging. Operating without formal registration, HTX DAO prioritizes autonomy, transparency, and inclusivity, making the HTX token essential for innovation, governance, and ecosystem growth in the blockchain space.
Read more on HTX →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
